[1] 光明日报.向病毒发出挑战,向科学探寻答案 ——中国生物新冠灭活疫苗研发团队攻关纪实[EB/OL].(2020-11-28)[2020-12-11] .https://politics.gmw.cn/2020-11/28/content_34410884.htm.
[2] Wang H, Zhang Y, Huang B, et al.Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2[J].Cell,2020,182(3):713-721.
[3] Xia S, Zhang Y, Wang Y, et al.Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: A randomised, double-blind, placebo-controlled, phase 1/2 trial[J].Lancet Infect Dis,2021,21(1):39-51.
[4] Xia S, Duan K, Zhang Y, et al.Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials[J].JAMA,2020,324(10):951-960.
[5] 和讯网.全球首个新冠灭活疫苗生产车间通过国家生物安全检查[EB/OL].(2020-08-05)[2020-12-11].https://baijiahao.baidu.com/s?id=1674177736322206938&wfr=spider&for=pc.
[6] Zhang Y, Zeng G, Pan H, et al.Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial[J]. Lancet Infect Dis, 2021,21(2):181-192.
[7] 莫斯科威.终于来了！首款国产新冠疫苗获批上市[EB/OL].(2020-12-31)[2021-02-03].http://www.360doc.com/content/20/1231/13/10240337_954541027.shtml.
[8] Xia S, Duan K, Zhang Y, et al.Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: Interim analysis of 2 randomized clinical trials[J].JAMA,2020,324(10):951-960.
[9] Al Kaabi N, Zhang Y, Xia S, et al.Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: A randomized clinical trial[J].JAMA, 2021,26:e218565.
[10] 中国生物技术网.科兴疫苗三期临床数据披露:保护效力为50.7%,100%预防重症新冠[EB/OL].(2021-04-13)[2021-05-03].https://baijiahao.baidu.com/s?id=169689722369731 2726&wfr=spider&for=pc.
[11] 腾讯网.3岁以上都可打！科兴:接种第3针疫苗抗体提升10倍[EB/OL].(2021-06-05) [2021-06-06].https://new.qq.com/rain/a/20210605A0BB5J00.
[12] Kai Kupferschmidt. U.K. variant puts spotlight on immunocompromised patients’ role in the COVID-19 pandemic[EB/OL].(2020-12-23) [2021-06-06].https://www.sciencemag.org/news/2020/12/uk-variant-puts-spotlight-immunocompromised-patients-role-covid-19-pandemic.
[13] 北京日报.印度研究机构:变异毒株Delta对接种过疫苗的人仍具有高度传染性[EB/OL].(2021-06-11)[2021-06-13].https://baijiahao.baidu.com/s?id=1702222856100360161&wfr=spider&for=pc.
[14] 环球网.国家卫健委:持续开展疫苗接种让更多群众尽快获得有效保护[EB/OL].(2021-06-12) [2021-06-13].https://baijiahao.baidu.com/s?id=1702344272001716089&wfr=spider&for=pc. |
